ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies on how long-term exposure may affect a fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should weigh the benefits of taking it against the potential risks for the fetus. Physicians don't have the data to give clear advice however they can provide information about risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to assess the frequency types Of Adhd medication structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to ensure that the classification was correct and to minimize any bias.

The study of the researchers had some limitations. The researchers were not able, in the first place to distinguish the effects caused by the medication from the disorder. This makes it difficult for researchers to determine if the small differences observed between the groups that were exposed to medication use or if they were caused by co-morbidities. The researchers did not examine long-term outcomes for the offspring.

The study showed that babies whose mothers had taken ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU), compared to those whose mothers did not take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases didn't appear to be influenced by the type of medication that was used during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits to both the mother and child of continuing treatment for the woman's condition. Doctors should discuss with their patients about this and try to help them develop coping skills that could reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the dilemma of whether to continue or end treatment during pregnancy is one that more and more physicians have to face. These decisions are usually taken without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge and experience, as well as the experiences of other doctors and the research on the topic.

Particularly, the issue of potential risks to the baby can be a challenge. Many studies on this issue are based on observations rather than controlled research and their findings are often contradictory. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study presented in the journal club addresses these issues by analyzing information on deceased and live births.

Conclusion: While some studies have found an association between adhd medication over the counter uk medications and certain birth defects However, other studies haven't found a correlation. Most studies show an unintended, or slight negative effect. As a result, a careful risk/benefit analysis must be conducted in every situation.

It can be challenging, if not impossible, for women suffering from adhd anxiety medication to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. A loss of medication may also affect the ability to safely drive and perform work-related tasks, which are crucial aspects of daily life for those with ADHD.

She recommends women who are unsure about whether to keep or stop medication in light of their pregnancy should consider informing family members, friends and colleagues about the condition, its impact on daily functioning, and the benefits of keeping the current treatment plan. It will also help a woman feel more confident in her decision. It is important to note that certain medications are able to pass through the placenta, so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be transferred to the child.

Birth Defects Risk

As the use and misuse of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the potential adverse effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Using two massive data sets researchers were able analyze more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. Researchers discovered that although the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The authors of the study could not discover any connection between early medication usage and congenital anomalies like facial deformities, or club feet. The results are in line with previous studies showing the presence of a small, but significant increase in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. The risk increased in the latter part of pregnancy when a large number of women stopped taking their medication.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean delivery, have a low Apgar after birth and have a baby who needed help breathing at birth. However the authors of the study were unable to eliminate selection bias by restricting the study to women who did not have other medical issues that could have contributed to the findings.

Researchers hope their research will inform physicians when they see pregnant women. They suggest that although discussing the benefits and risks is important but the decision to stop or continue medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, although stopping the medication is an option to consider, it is not recommended because of the high incidence of depression and other mental disorders in women who are expecting or have recently given birth. Additionally, research suggests that women who stop taking their medications will have a harder transitioning to life without them once the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments, preparing for the arrival of a child and adapting to new routines in the home are often faced with a number of difficulties. As such, many women decide to continue taking their ADHD medication throughout the pregnancy.

The risk to nursing infant is low because the majority of stimulant medications passes through breast milk at low levels. However, the rate of exposure to medications by the newborn may differ based on dosage, how often it is taken and the time of the day the medication is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract or through breast milk. The effect on the health of a newborn isn't fully known.

Because of the lack of research, some physicians may be inclined to discontinue stimulant medication during the course of pregnancy. This is a difficult decision for the patient, who must balance the benefits of keeping her medication against the potential dangers to the fetus. Until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal period.

Many studies have shown that women can continue taking their different adhd medications medication without risk during pregnancy and breast-feeding. As a result, many patients choose to do so and after consulting with their doctor, they have discovered that the benefits of maintaining their current medication outweigh any risks.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons for continuing treatment. This includes best non stimulant adhd medication for adults-pharmacological strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD be aware of their symptoms and underlying disorder, learn about available treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration, and, if needed modifications to the medication regime.